M. Tsugawa

发表

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

I. Shimomura, H. Kaneto, T. Matsuoka, 2021, Diabetes Therapy.

Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study

I. Shimomura, H. Kaneto, H. Yokoyama, 2020, Cardiovascular Diabetology.

Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan.

T. Funahashi, I. Shimomura, T. Matsuoka, 2016, Endocrine journal.

Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)

I. Shimomura, H. Kaneto, H. Yokoyama, 2016, Diabetes Care.

Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)

I. Shimomura, H. Kaneto, H. Yokoyama, 2014, Diabetology & Metabolic Syndrome.

Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity

T. Funahashi, I. Shimomura, S. Fukuda, 2013, Cardiovascular Diabetology.

LONG-TERM FOLLOW-UP OF A PATIENT WITH SPORADIC NONAUTOIMMUNE HYPERTHYROIDISM DUE TO A THYROTROPIN-RECEPTOR MUTATION (D619G)

M. Hirokawa, A. Miyauchi, Mitsuru Ito, 2018 .

Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study

I. Shimomura, H. Kaneto, H. Yokoyama, 2017, Diabetes Therapy.

Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

I. Shimomura, H. Kaneto, H. Yokoyama, 2021, Cardiovascular Diabetology.

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

I. Shimomura, H. Kaneto, T. Matsuoka, 2023, Cardiovascular Diabetology.

Usefulness of ultrasonographic estimation of preperitoneal and subcutaneous fat thickness in the diagnosis of nonalcoholic fatty liver disease in diabetic patients

Y. Imai, Yoshiyuki Sawai, K. Fukuda, 2015, Journal of Medical Ultrasonics.

Contribution of Asian haplotype of KCNJ18 to susceptibility to and ethnic differences in thyrotoxic periodic paralysis.

Y. Hiromine, H. Ikegami, Y. Kawabata, 2019, The Journal of clinical endocrinology and metabolism.

Augmented induction by dexamethasone of metallothionein IIa messenger ribonucleic acid in fibroblasts from a patient with cortisol hyperreactive syndrome.

M. Gomi, M. Tsugawa, T. Kitani, 1993, The Journal of clinical endocrinology and metabolism.

[A case of non-small cell lung carcinoma successfully treated with carboplatin and weekly paclitaxel under renal dysfunction].

I. Akedo, K. Tamura, M. Tsugawa, 2004, Gan to kagaku ryoho. Cancer & chemotherapy.

O R I G I N a L I N V E S T I G a T I O N Open Access Vascular Complications and Changes in Body Mass Index in Japanese Type 2 Diabetic Patients with Abdominal Obesity

T. Funahashi, I. Shimomura, S. Fukuda, 2022 .

A patient with hypocortisolism and Cushing's syndrome-like manifestations: cortisol hyperreactive syndrome.

J. Fukata, S. Tarui, Junichi Nishimura, 1990, The Journal of clinical endocrinology and metabolism.